Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
äŒæ¥ã³ãŒãBIO
äŒç€ŸåBio Rad Laboratories Inc
äžå Žæ¥Mar 17, 1980
æé«çµå¶è²¬ä»»è
ãCEOãSchwartz (Norman D)
åŸæ¥å¡æ°7700
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Mar 17
æ¬ç€Ÿæåšå°1000 Alfred Nobel Dr
éœåžHERCULES
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·94547
é»è©±çªå·15107247000
ãŠã§ããµã€ãhttps://www.bio-rad.com/
äŒæ¥ã³ãŒãBIO
äžå Žæ¥Mar 17, 1980
æé«çµå¶è²¬ä»»è
ãCEOãSchwartz (Norman D)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã